QPP Measure #CAP34
Molecular Assessment: Biomarkers in Non-Small Cell Lung Cancer
Percentage of non-small cell lung cancer (NSCLC) pathology reports that include anaplastic lymphoma kinase (ALK), epidermal growth factor receptor (EGFR), AND tyrosine protein kinase ROS1 mutation status.
Submission Methods: Registry
The following codes apply for this QPP measure:
HCPCS Codes | |||
| Code | Description | ||
|---|---|---|---|
| M1501 | Pathology mips value pathway | ||
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com